PAX3 and neoplasm: Jothi et al. demonstrated that pharmacologically induced AKT activation leads to the phosphorylation-dependent inhibition of PAX3-FOXO1, the suppression of tumor-cell growth and invasiveness, and the induction of apoptosis in vitro, along with reduced tumor burden in xenograft models [334,335].